Skip to Content
Kyle A. Richards, MD, FACS

Contact Dr. Richards


(608) 262-0759

MADISON, WI 53705-2281

Kyle A. Richards, MD, FACS

Assistant Professor (CHS)


  • Urologic Oncology Fellowship, University of Chicago, Chicago, IL, 2014
  • Internship and Residency, Wake Forest University Baptist Medical Center, Winston-Salem, NC, 2007-2012
  • MD, Medical College of Wisconsin, Milwaukee, WI, 2007
  • BA, Biology and Neuroscience, Carthage College, Kenosha, WI, 2003

Clinical Specialties

Dr. Richards is fellowship trained in urologic oncology, with a special interest in treating patients with bladder, prostate, kidney and testicular cancers. He specializes in open and robotic procedures. Dr. Richards’ philosophy is to provide the best possible urological care for his patients.

Research Interests

Dr. Richards conducts clinical, translational and health services research in urologic oncology. He has special interests in quality improvement projects aimed at streamlining health care delivery and efficiency for all patients with urologic malignancies.

Recent Publications
  • Richards KA, Ruiz VL, Murphy DR, Downs TM, Abel EJ, Jarrard DF, Singh H. Diagnostic evaluation of patients presenting with hematuria: An electronic health record-based study. Urol. Oncol. 2018 Mar; 36(3):88.e19-88.e25.
    [PubMed ID: 29169843]
    More Information
  • Wang JH, Downs TM, Jason Abel E, Richards KA, Jarrard DF. Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies. Curr Urol Rep 2017 Jul; 18(7):48.
    [PubMed ID: 28589399]
    More Information
  • Blute ML, Kucherov V, Rushmer TJ, Damodaran S, Shi F, Abel EJ, Jarrard DF, Richards KA, Messing EM, Downs TM. Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression. BJU Int. 2017 09; 120(3):387-393.
    [PubMed ID: 28464520]
    More Information
  • Tazeh NN, Canter DJ, Damodaran S, Rushmer T, Richards KA, Abel EJ, Jarrard DF, Downs TM. Neutrophil to Lymphocyte Ratio (NLR) at the Time of Transurethral Resection of Bladder Tumor: A Large Retrospective Study and Analysis of Racial Differences. Bladder Cancer 2017 Apr 27; 3(2):89-94.
    [PubMed ID: 28516153, PMCID: 5409044]
    More Information
  • Murphy DR, Meyer AN, Vaghani V, Russo E, Sittig DF, Richards KA, Wei L, Wu L, Singh H. Application of Electronic Algorithms to Improve Diagnostic Evaluation for Bladder Cancer. Appl Clin Inform 2017 Mar 22; 8(1):279-290.
    [PubMed ID: 28326433, PMCID: 5373770]
    More Information
  • Richards KA, Cesario S, Lim AH, Best SL, Deeren SM, Bushman W, Safdar N. Utility of routine urinalysis and urine culture testing in an ambulatory urology clinic: a quality improvement initiative in a Veterans healthcare facility. Can J Urol 2017 Feb; 24(1):8627-8633.
    [PubMed ID: 28263127]
    More Information
  • Richards KA, Abel EJ. Surveillance following surgery for nonmetastatic renal cell carcinoma. Curr Opin Urol 2016 Sep; 26(5):432-8.
    [PubMed ID: 27467135]
    More Information
  • Grimes MD, Blute ML, Wittmann TA, Mann MA, Zorn K, Downs TM, Shi F, Jarrard DF, Best SL, Richards KA, Nakada SY, Abel EJ. A Critical Analysis of Perioperative Outcomes in Morbidly Obese Patients Following Renal Mass Surgery. Urology 2016 Oct; 96():93-98.
    [PubMed ID: 27339026]
    More Information
  • Hemal S, Krane LS, Richards KA, Liss M, Kader AK, Davis RL. Risk factors for infectious readmissions following radical cystectomy: results from a prospective multicenter dataset. Ther Adv Urol 2016 Jun; 8(3):167-74.
    [PubMed ID: 27247626, PMCID: 4872190]
    More Information
  • Richards KA, Ham S, Cohn JA, Steinberg GD. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities. Int. J. Urol. 2016 Jan; 23(1):42-7.
    [PubMed ID: 26443388]
    More Information Copyright © 2018 The Board of Regents of the University of Wisconsin System